SUBSCRIBE
SUBSCRIBE

Actio Biosciences, Inc.

NEWS
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
Press Releases
Actio Biosciences to Participate in Upcoming Investor Conferences
November 12, 2024
 · 
1 min read
Business
Actio Biosciences to Participate in Upcoming October Investor Conferences
September 25, 2024
 · 
1 min read
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
May 22, 2024
 · 
2 min read
Business
Actio Biosciences Appoints Samuel Collins, MBBS, Ph.D., MBA, as Chief Medical Officer as Company Advances Multiple Precision Medicine Programs Toward Clinical Development
January 24, 2024
 · 
2 min read
Biotech Beach
Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases
September 12, 2023
 · 
6 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS